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Abstract
Background: Financial hardships experienced by cancer survivors have become a prominent public health issue in the United
States. Few studies of financial hardship have assessed financial holdings, including assets, debts, and their values,
associated with a cancer history.
Methods: Using the 2008–2011 Medical Expenditure Panel Survey, we identified 1603 cancer survivors and 34 915 individuals
age 18–64 years without a cancer history to assess associations between self-reported cancer history and assets, debts, and
net worth. Distributions of self-reported asset and debt ownership, their values, and net worth were compared for adults
with and without a cancer history with chi-square statistics. Multivariable ordered probit regression analysis was conducted
to assess the association between cancer history and net worth using a two-sided Wald test. All analyses were stratified by
age group (18–34, 35–44, 45–54, and 55–64 years). Statistical tests were two-sided.
Results: Among those age 45–54 years, cancer survivors had a lower proportion of home ownership than individuals without
a cancer history (59.0% vs 67.1%, P ¼ .0014) and were statistically significantly more likely to have negative net worth (–
$3000) and less likely to have positive net worth ($3000). Cancer survivors were more likely to have debt than individuals
without a cancer history, especially among those age 18–34 years (41.3% vs 27.1%, P < .001).
Conclusions: Cancer history is associated with lower asset ownership, more debt, and lower net worth, especially in
survivors age 45–54 years. Longitudinal studies of financial holdings will be important to inform development of interven-
tions to reduce financial hardship.
The number of cancer survivors is expected to grow from 15.5
million in 2016 to 20.3 million by 2026 in the United States (1)
due to an aging and growing population and increasing sur-
vival resulting from improvements in early detection and
treatment. The cost of cancer treatment is also expected to
increase over this time. The average launch price of a new
therapeutic agent in oncology has increased by an average of
$8500 per year (2), from 1995 to 2013, and currently novel anti-
cancer drugs can cost more than $60 000 for a month of treat-
ment (3). Cancer survivors and their family caregivers may
also experience limitations in ability to work (4,5), reducing
household income and limiting access to employer-based
health insurance. Consequently, the medical costs associated
with cancer have led to considerable financial hardship for
survivors, especially the working-age population and their fami-
lies (6). Recent studies estimated that between 13% and 34% of
working-age cancer survivors (age 18–64 years) report ever hav-
ing to borrow money or go into debt because of cancer, its treat-
ment, or lasting effects of treatment (6,7), about six times the
proportion of cancer survivors age 65 years and older (6).
Younger age (<40) is also associated with up to 10 times the
rate of bankruptcy filings among cancer survivors (8).
Empirical studies have demonstrated that financial hardship
is associated with lower adherence to cancer treatments (9–12),
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lower quality of life and perceived quality of care (13,14), and
subsequently poorer health outcomes, including increased mor-
tality (15). Thus, financial hardship is also an increasingly sig-
nificant social and public health issue.
As mentioned previously, material measures of financial
hardship are typically measured as out-of-pocket spending by
survivors for their medical care and health care in general and
productivity loss, including lost income, missed work days, in-
ability to participate in usual activities, or family members’ per-
sonal leave from work. However, the scope of financial
hardship in cancer survivors is not particularly well understood,
and few studies have assessed the underlying financial hold-
ings, including ownership of assets, debts, and their values, as
novel measures of financial hardship of individuals following a
cancer diagnosis compared with those without a cancer history.
An older study used data from the 2002 Health and Retirement
Study to examine assets in cancer survivors and individuals
without a cancer history age 55 years and older, but information
was not available about the working-age population younger
than age 55 years, which is likely to be most vulnerable to the
risk of financial hardship (16). In addition, these data were col-
lected before more modern high-cost cancer care and did not in-
clude any information about debt or net worth. Other studies of
debt in cancer survivors have been limited by lack of a compari-
son group without a cancer history (6,7) or have been conducted
in defined geographic regions and were not representative of
the US population (8). In this study, we used nationally repre-
sentative data to assess the association between a cancer his-
tory and asset ownership, debts, and net worth among working-
age individuals age 18–64 years.
Methods
Data Source and Study Population
This cross-sectional study used data from the 2008–2011
Medical Expenditure Panel Survey (MEPS) Household
Component sponsored by the Agency for Healthcare Research
and Quality (AHRQ). The MEPS is an ongoing nationally repre-
sentative survey of health insurance, access to care, utilization,
and health care expenditures in the US civilian noninstitution-
alized population. In-person interviews are conducted with a
family member who typically responds for all family members
in the household over a two-year period consisting of five
rounds of interviews. Asset and debt data are collected in round
5 only and are considered restricted use (only available through
the AHRQ Data Center); 2008–2011 are the most recently avail-
able years of the survey with edited and reliable asset and debt
data (17). MEPS estimate of net worth and asset holdings com-
pare well to the Survey of Income and Program Participation
(SIPP), and MEPS is comparable along many dimensions to the
Survey of Consumer Finances (SCF), (17,18). These survey years
had a combined average annual response rate ranging from 54%
to 59%. More information about survey design and content is
available from http://www.meps.ahrq.gov/mepsweb/.
We identified 1603 working-age cancer survivors age 18–64
years based on responses to the question “Have you ever been
told by a doctor or other health professional that you had cancer
or a malignancy of any kind?” Individuals who did not respond
to this question were excluded from the study. Consistent with
prior studies, individuals who reported only a diagnosis of non-
melanoma skin cancer were not classified as cancer survivors
and were included in the comparison group (19–21).
The comparison group included 34 915 individuals age 18–64
years without a self-reported history of cancer.
Measures
Sample Characteristics
Sample characteristics for adults with and without a self-
reported cancer history included age (18–34, 35–44, 45–54, and
55–64 years), sex, race/ethnicity (non-Hispanic white and other),
marital status (married and not married/other), educational at-
tainment (<high school and high school), family size (1, 2 [eg,
husband and wife or parent and child], and 3þ), family income
as percentage of the federal poverty line (FPL; <399%, and
400%), employment (employed and not employed), health in-
surance type (private, any public, uninsured), and survey year.
Comorbid conditions were identified with a series of questions
about whether a doctor or other health professional ever told
the person they had any MEPS priority condition, including ar-
thritis, asthma, diabetes, emphysema, coronary heart disease,
hypertension, stroke, angina, and high cholesterol. Comorbid
conditions were categorized by the number of MEPS priority
medical conditions (0, 1, 2þ). Time since cancer diagnosis and
receipt of any cancer treatment during the year of the survey
were measured only for cancer survivors.
Measures of Wealth
Measures of wealth included financial assets, debt, and net
worth, which were estimated as previously described by
Bernard et al. (17). Briefly, total financial assets included owner-
ship and value of first home, vehicles, checking and savings
accounts, other financial assets (ie, money market funds,
stocks, government and corporate bonds, mutual funds, certifi-
cates of deposit), individual retirement accounts (ie, IRA, Keogh
and 401(k)), other properties (ie, second homes, rental real es-
tate, a business or farm, boats, trailer, or other recreational
vehicles). Total debt included ownership and value of debts re-
lated to home, vehicles, second homes, rental real estate, a
business or farm, boats or other recreational vehicles, credit
card balances, debts owed to medical providers, life insurance
policy loans, loans from relatives and other significant sources.
Net worth was estimated as the value of all assets minus debts.
Given that economic resources are shared among family mem-
bers, measures of assets, debt, and income were estimated at
the family level in MEPS. We categorized net worth using a
$3000 cutoff (negative net worth  –$3000; –$2999  net worth 
þ$2999; and positive net worth  þ$3000) to represent monthly
median household income after approximately 30% tax deduc-
tions in the period these data were collected, 2008–2011 (22–24).
Analyses
Descriptive statistics were calculated for all sample demo-
graphic and socioeconomic characteristics. Distributions of self-
reported asset and debt ownership, their values, and net worth
were compared for adults with and without a cancer history
with chi-square statistics. Analyses were stratified by age group
(18–34, 35–44, 45–54, and 55–64 years) to reflect phases of the life
course with respect to debt and asset accumulation.
Multivariable ordered probit regression analysis was con-
ducted to assess the association between cancer history and net
worth. We present unadjusted, partially adjusted, and fully ad-
justed predicted probabilities of cancer history and each of the
net worth categories to first evaluate the effects of patient
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demographic characteristics and then the addition of socioeco-
nomic characteristics on these associations. Partially adjusted
model covariates included sex, race/ethnicity, marital status,
and number of comorbid conditions. Additional covariates in
the fully adjusted models were educational attainment, family
size, family income as percentage of FPL, employment status,
type of health insurance, and survey year. All estimates were
weighted to account for the MEPS complex survey design and
survey nonresponse using Stata, version 13.1 (College Station,
TX, USA). Two-sided P values were calculated using the Wald
test. Comparisons with P values of less than .05 were considered
statistically significant.
Results
Compared with individuals without a cancer history, survivors
were relatively older (47.3% vs 17.8% age 55–64 years), mostly fe-
male (65.9% vs 49.8%), and less likely to be employed (64.2% vs
76.1%) (Table 1). Cancer survivors were also more likely to have
two or more comorbid conditions (49.9% vs 23.9%) and less likely
to not have any comorbid conditions (25.9% vs 52.6%) than those
without a cancer history. Cancer survivors were less likely to be
uninsured and more likely to have higher educational attainment
and higher income as a percentage of the FPL. Of the cancer survi-
vors, the clear majority were more than two years since first can-
cer diagnosis (81.6%) and not receiving cancer treatment at the
time of the survey (81.8%). Therefore, the sample of cancer survi-
vors was comprised mainly of longer-term cancer survivors with
at least one additional chronic condition.
Asset Ownership
Asset ownership was higher among cancer survivors and indi-
viduals without a cancer history in the older age groups than
the younger age groups. Among the group age 45 to 54 years,
the proportion reporting family home ownership was statisti-
cally significantly lower for cancer survivors than those without
a cancer history (59.0% vs 67.1%, P ¼ .0014) (Figure 1). Asset own-
ership was similar for cancer survivors and individuals without
a cancer history in the other age groups.
Debt
Among those age 18 to 34 years, a statistically significantly
higher proportion of cancer survivors reported debt ownership
than individuals without a cancer history (41.3% vs 27.1%, P <
.001) (Figure 1; Appendix Table 1). In the group age 45–54 years,
cancer survivors also had a higher proportion of debt ownership
than individuals without a cancer history, although the differ-
ence was only marginally significant (36.5% vs 32.1%, P ¼ .06).
Net Worth
The summary of assets and debt values for cancer survivors
and individuals without a cancer history who reported owner-
ship is shown in Figure 2. No statistically significant differences
were observed in the reported mean assets and debt values of
cancer survivors compared with individuals without a history
of cancer in the same age groups.
Relative to those without a history of cancer, the unadjusted
and adjusted likelihood of cancer survivors falling into three net
worth categories is depicted in Table 2. Cancer survivors age
45–54 years were statistically significantly more likely to have a
negative net worth and statistically significantly less likely to
have a positive net worth than those individuals without a his-
tory of cancer (1.5%, 95% confidence interval [CI] ¼ 0.2 to 2.7,
and –4.7%, 95% CI ¼ –9.0 to –0.6, respectively). Cancer survivors
in the 18–34 age category were also more likely to have a nega-
tive net worth and less likely to have a positive net worth (2.3%,
95% CI ¼ –0.2 to 4.7, and –5.8%, 95% CI ¼ –12.1 to 0.5, respec-
tively), although this was only statistically significant in unad-
justed and partially adjusted models.
Discussion
Using nationally representative data from the MEPS, we found
that among those age 45–54 years, cancer survivors had a lower
proportion of home ownership than individuals without a can-
cer history. They were also more likely to have a negative net
worth, even after controlling for key sociodemographic charac-
teristics, including educational attainment, family income as a
percentage of the FPL, employment status, and type of health
insurance, as well as prevalence of other comorbid conditions,
which are more common among cancer survivors. The propor-
tion of cancer survivors with debt was higher than individuals
without a history of cancer, especially in the 18–34 years age
group. These findings suggest that, compared with those with-
out a cancer history, working-age individuals with a history of
cancer have less financial stability, even many years after a can-
cer diagnosis. Longitudinal population-based studies will be im-
portant to assessing causality, patterns of debt, assets, and net
worth throughout the cancer survivorship experience and to
informing the development of interventions to reduce financial
hardship.
Our study contributes to a growing body of research (25) doc-
umenting the financial hardships associated with a cancer diag-
nosis, including 1) material conditions that develop as a result
of out-of-pocket expenses and lower income from inability to
work, 2) psychological responses to costs associated with diag-
nosis, its treatment, and lasting effects of treatment, and 3) cop-
ing behaviors used to manage increased expenditures and
reduced income during and following cancer care. These coping
behaviors may include filling a prescription or delaying the start
of a treatment (12,26), nonadherence to treatment (27), or aban-
donment of a therapy (28). Given the late- and long-term effects
associated with treatment, increased risk of second cancers (29–
31) and other chronic conditions (32), and the need for contin-
ued surveillance, such behaviors may adversely affect health
outcomes among cancer survivors and result in higher medical
expenditures and increased risk of mortality (13,15,33–36).
Recent studies have highlighted the elevated economic burden
associated with additional chronic conditions among cancer
survivors (20,37). To our knowledge, our measures of financial
hardship are novel, and the prevalence of both debt and assets
or net worth has not been assessed using the MEPS or other
data sources for working-age adults with other conditions, such
as heart disease, or in adults identified as having high medical
spending in the past year. As a result, it is unclear whether our
findings are specific to cancer survivors or are also consistent
for adults with other conditions having high medical costs com-
pared with similar adults without those conditions. These will
be important areas for additional research.
We found that assets and net worth, at the time of the sur-
vey, varied substantially by age group for both cancer survivors
and individuals without a cancer history, with greatest home
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ownership and asset value in the older age groups (ie, 45–54 and
55–64 years). While not unexpected, these data suggest that
considerations of life course are critical in the evaluation of fi-
nancial hardship.
An older study examined assets and cancer history, based
on the 2002 Health and Retirement Study in older Americans
(55 years, mean age ¼ 68 and 69 years for men and women, re-
spectively) (16). Cancer survivors were defined as those who
were diagnosed four or more years before the survey and did
not receive treatment for their cancer in the preceding two
years. This study referred to net worth but only measured the
sum of housing equity and other assets and, unlike our study,
did not incorporate debt into the measure. Further, the study
found that male cancer survivors and those without a history of
cancer had similar income and assets, but differed somewhat in
net worth, although no association was observed between can-
cer history and assets among females (16). In our study, we did
not have a sufficient sample to stratify our measures by both
age group and sex. Exploring the effects of key demographic
and socioeconomic characteristics on asset and debt accumula-
tion over the life course will be an important area for future
research.
The MEPS is the only nationally representative database
containing specific questions devoted to asset and debt catego-
ries (ie, home ownership, car ownership, debts related to home,
vehicles, and businesses) for adults of all ages and types of
health insurance, as well as the uninsured. However, these
unique data were only available through 2011, prior to imple-
mentation of many changes in health insurance as part of the
Affordable Care Act (ACA). Our results provide important base-
line information in evaluating the effects of the ACA and other
insurance changes on debt accumulation, safeguarding of
household assets, and risk of financial hardship for cancer sur-
vivors. Several provisions of the ACA are especially relevant to
cancer survivors, including Medicaid eligibility expansions in
some states, allowing dependent children to remain on their
parents’ employment-based health insurance until age 26 years,
elimination of annual and lifetime limits on coverage for essen-
tial health benefits, caps on out-of-pocket spending, and insur-
ance premium tax credits and cost-sharing subsidies for
individuals and families who meet eligibility requirements (7).
As additional years of the MEPS asset module data become
available, further investigations of the effects of changes in
health insurance coverage in working-age adults are warranted.
Although this study provides unique information about
measures of wealth, including assets, debt, and net worth, and
will inform future studies of financial hardship, certain limita-
tions should be noted. First, not all MEPS participants completed
the MEPS assets module in round 5, but the distributions of soci-
odemographic characteristics, including age, sex, race/ethnicity,
marital status, educational attainment, and number of MEPS
priority conditions, in our sample and in other studies of cancer
survivors and individuals without a cancer history using the
MEPS are similar (20). Second, our study data, including finan-
cial holdings and cancer history, were self-reported and there-
fore subject to recall bias and misclassification. Third, for
cancer survivors, we did not have information about stage at di-
agnosis, types of treatment(s) received, cancer recurrence, and
other clinical characteristics likely to be associated with treat-
ment. Fourth, the small number of survivors with specific can-
cers in our sample precluded us from reporting the results by
cancer type. Patterns of asset and debt accumulation and em-
ployment options may vary substantially by cancer type and
age at diagnosis. For example, survivors of pediatric cancers
Table 1. Characteristics of sample population
Cancer survivor
(n ¼ 1603)
No history of
cancer
(n ¼ 34 915)
No.
(weighted %)
No.
(weighted %)
Chi-
square P
Age, y
18–34 192 (10.6) 13 513 (38.2) <.01
35–44 241 (14.3) 7772 (21.4) <.01
45–54 457 (27.8) 7796 (22.6) <.01
55–64 713 (47.3) 5834 (17.8) <.01
Sex
Male 482 (34.1) 1 612 (50.2) <.01
Female 1121 (65.9) 18 303 (49.8) <.01
Race/ethnicity
White, non-Hispanic 1055 (80.6) 15 153 (64.4) <.01
Black, Hispanic, other 548 (19.4) 19 762 (35.6) <.01
Marital status
Married 882 (59.5) 17 759 (52.5) <.01
Not married 721 (40.5) 17 156 (47.5) <.01
Education*
Less than high school 280 (11.9) 8492 (17.2) <.01
High school grad/
college
1319 (88.1) 26 264 (82.8) <.01
Family size
Single 292 (20.2) 4847 (17.1) <.01
Dyad 579 (38.9) 7956 (26.6) <.01
3þ 732 (40.9) 22 112 (56.2) <.01
Family income, % FPL
<399 1017 (53.5) 24 293 (59.1) <.01
400þ 586 (46.5) 10 604 (40.9) <.01
Employment status
Employed 956 (64.2) 25 165 (76.1) <.01
Retired/not employed/
other
647 (35.8) 9750 (23.9) <.01
Health insurance
Private 1029 (73.8) 21 266 (70.7) <.01
Public only 357 (15.7) 5155 (10.5) <.01
Uninsured 217 (10.5) 8494 (18.8) <.01
No. of comorbid conditions
0 409 (25.9) 18 743 (52.6) <.01
1 364 (24.2) 7946 (23.5) .96
2þ 830 (49.9) 8226 (23.9) <.01
Year
2008 343 (20.6) 7030 (20.9) .22
2009 466 (29.2) 10 360 (27.9) .61
2010 427 (27) 9276 (27.7) .95
2011 367 (23.2) 8249 (23.4) .5
Years since first cancer diagnosis
1 206 (13.1) N/A
2–5 459 (28.8)
6–9 267 (16.1)
10–19 358 (22.7)
20 213 (14)
Missing 100 (5.3)
In treatment†
Yes 274 (18.2)
No 1329 (81.8)
*Out of 1603 cancer survivors, four had missing values for educational attain-
ment. Out of 34 915 individuals without a history of cancer, 159 had missing val-
ues. FPL ¼ federal poverty level.
†In treatment was defined as receiving chemotherapy or radiation therapy for a
cancer condition in either an outpatient or office-based setting or having a pre-
scription for an antineoplastic medication.
4 of 7 | JNCI J Natl Cancer Inst, 2018, Vol. 0, No. 0
Downloaded from https://academic.oup.com/jncics/article-abstract/2/2/pky004/5026705
by University of Newcastle user
on 03 July 2018
who received treatment during key developmental stages may
have significant late and lasting effects of cancer and its treat-
ment that affect employment, whereas early-stage breast can-
cer survivors with limited treatment may have few health
effects and little employment disruption. Fifth, because the can-
cer diagnosis question refers to cancer or malignancy of any
kind, it may have included individuals with pre-invasive dis-
ease. However, any misclassification of cancer history would
likely bias our comparisons with individuals without a cancer
history to a null association. Sixth, although a previous study
surmised that poverty could place patients at greater risk for
certain types of cancer (38), this doesn’t seem to be the mecha-
nism in our sample. The cancer survivors in our study had
higher insurance coverage, education level, and income.
Further longitudinal studies are needed to tease apart whether
cancer itself is the cause of poverty. Seventh, the most recent
years of the assets section available were 2008–2011, which may
not reflect current values. These years include the recent eco-
nomic downturn in the United States. However, the proportion
of cancer survivors and individuals without a cancer history in-
cluded for each year were similar, our study compared cancer
survivors and individuals without a cancer history (rather than
trends), and we included survey year in our multivariable analy-
ses. As a result, we do not believe that any specific year had a
particular impact on our findings. Nonetheless, it is possible
that the economic downtown might have affected cancer survi-
vors more than other Americans in their assets, debts, and net
worth as survivors were more susceptible to changes in employ-
ment and health insurance coverage or faced greater expenses
due to their cancer diagnosis and greater comorbidity. Future
studies are needed to confirm the magnitudes of difference ob-
served in our study. Finally, as our study was cross-sectional
across MEPS interview years, we were unable to assess the
causal nature of the observed associations.
Our cross-sectional study provides evidence of material
measures of financial hardship that working-age cancer survi-
vors and their households may experience. We assessed the as-
sociation between cancer history and the components of net
worth and identified the age groups most affected by a cancer
diagnosis. We found that cancer history has an association with
asset ownership, debt, and net worth, especially in those age
45–54 years. Longitudinal studies that assess the causality and
patterns of financial holdings throughout the cancer experience
are warranted.
Figure 1. Home and debt ownership by cancer status. A) Home ownership by cancer status. P ¼ .0014 for age group 45–54 years, chi-square test. B) Debt ownership by
cancer status. P < .001 for age group 18–34 years, chi-square test. *P < .05.
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Figure 2. Debts and assets values (2011 dollars) in cancer survivors and in individuals without a cancer history who reported ownership by age group. A) Owned assets
and debt values in age group 18–34 years by cancer status. Error bars represent the 95% confidence interval. B) Owned assets and debt values in age group 35–44 years
by cancer status. Error bars represent the 95% confidence interval. C) Owned assets and debt values in age group 45–54 years by cancer status. Error bars represent the
95% confidence interval. D) Owned assets and debt values in age group 55–64 years by cancer status. Error bars represent the 95% confidence interval. Other asset value
refers to the values of all assets not including primary home and cars. Any asset value refers to the values of all assets.
Table 2. Cancer survivors and net worth categories relative to individuals without a history of cancer
Age group, y Unadjusted Mar eff (95% CI) Partially adjusted Mar eff (95% CI) Fully adjusted Mar eff (95% CI)
Negative net worth  –$3000
18–34 0.034* (0.008 to 0.060) 0.034* (0.009 to 0.060) 0.023 (–0.002 to 0.047)
35–44 0.025 (–0.001 to 0.051) 0.019 (–0.006 to 0.044) 0.010 (–0.013 to 0.033)
45–54 0.026* (0.009 to 0.042) 0.023* (0.008 to 0.038) 0.015* (0.002 to 0.027)
55–64 0.002 (–0.009 to 0.013) 0.007 (–0.002 to 0.016) 0.005 (–0.002 to 0.012)
–$2999  net worth  þ$2999
18–34 0.046* (0.011 to 0.081) 0.048* (0.012 to 0.085) 0.035 (–0.003 to 0.073)
35–44 0.030 (–0.001 to 0.062) 0.025 (–0.008 to 0.059) 0.016 (–0.021 to 0.053)
45–54 0.038* (0.014 to 0.063) 0.041* (0.014 to 0.068) 0.033* (0.004 to 0.062)
55–64 0.004 (–0.019 to 0.026) 0.018 (–0.006 to 0.042) 0.017 (–0.009 to 0.043)
Positive net worth  þ$3000
18–34 –0.080* (–0.141 to –0.018) –0.083* (–0.145 to –0.020) –0.058 (–0.121 to 0.005)
35–44 –0.055 (–0.114 to 0.002) –0.045 (–0.104 to 0.015) –0.026 (–0.086 to 0.034)
45–54 –0.064* (–0.105 to –0.023) –0.063* (–0.105 to –0.022) –0.047* (–0.090 to –0.006)
55–64 –0.006 (–0.038 to 0.027) –0.025 (–0.058 to 0.008) –0.022 (–0.054 to 0.011)
*P < .05. Marginal effect (Mar eff) shows the discrete change in probability when cancer status changes from 0 (without a history of cancer) to 1 (cancer survivor).
Partially adjusted model covariates included sex, race/ethnicity, marital status, and number of comorbid conditions. Additional covariates in the fully adjusted models
were educational attainment, family size, family income as percentage of the federal poverty level, employment status, type of health insurance, and survey year. CI ¼
confidence interval.
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Appendix Table 1. Asset ownership by age group
Cancer survivor
Without a
cancer history P
(n ¼ 1603) (n ¼ 34 915)
No. (weighted %) No. (weighted %)
Asset owner, age 18–34 y
Home 42 (24.6) 2281 (21) .32
Transportation Vehicle 111 (63.6) 7131 (59.1) .26
Other assets 108 (64.4) 6826 (59.8) .32
Any assets 134 (77.4) 8934 (73.8) .34
Asset owner, age 35–44 y
Home 117 (58.6) 3829 (57.8) .83
Transportation Vehicle 178 (80.7) 5762 (79.7) .75
Other assets 159 (74.8) 5135 (74.8) .99
Any assets 203 (89.4) 6512 (88.8) .78
Asset owner, age 45–54 y
Home 237 (59) 4648 (67.1) .00*
Transportation Vehicle 351 (82.4) 5866 (80.9) .50
Other assets 301 (71.9) 5362 (76.5) .08
Any assets 385 (89.0) 6696 (90.5) .26
Asset owner, age 55–64 y
Home 486 (73.4) 3846 (72.3) .59
Transportation Vehicle 567 (83.6) 4422 (81.4) .19
Other assets 534 (80.7) 4245 (79.5) .47
Any assets 641 (93.1) 5140 (92.0) .33
*P < .05.
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